Celestica (CLS) analyst forecast and price target
Analyst forecast
Consensus of 24 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Bernstein | Initiated Coverage | Outperform | $520.00 | Sep 30, 2026 |
| FBN Securities | Initiated Coverage | Outperform | $375.00 | Sep 15, 2026 |
| UBS | Upgraded | Neutral → Buy | $430.00 from $410.00 | Aug 24, 2026 |
| Scotiabank | Maintained | Sector Outperform | $500.00 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $406.00 from $430.00 | Aug 7, 2026 |
| Barclays | Maintained | Overweight | $430.00 from $441.00 | Jul 29, 2026 |
| Wolfe Research | Maintained | Outperform | $475.00 from $425.00 | Jul 29, 2026 |
| JP Morgan | Maintained | Overweight | $485.00 from $445.00 | Jul 29, 2026 |
| Rothschild & Co | Initiated Coverage | Buy | $460.00 | May 1, 2026 |
| Susquehanna | Maintained | Positive | $510.00 from $460.00 | Apr 29, 2026 |
| Barclays | Maintained | Overweight | $441.00 from $391.00 | Apr 29, 2026 |
| RBC Capital | Maintained | Outperform | $440.00 from $400.00 | Apr 29, 2026 |
| TD Cowen | Upgraded | Hold → Buy | $430.00 from $350.00 | Apr 29, 2026 |
| Citigroup | Maintained | Buy | $415.00 from $338.00 | Apr 29, 2026 |
| UBS | Maintained | Neutral | $400.00 from $355.00 | Apr 29, 2026 |
| JP Morgan | Maintained | Overweight | $425.00 from $410.00 | Apr 29, 2026 |
| BMO Capital | Maintained | Outperform | $450.00 from $370.00 | Apr 24, 2026 |
| TD Cowen | Maintained | Hold | $350.00 from $330.00 | Apr 20, 2026 |
| B of A Securities | Maintained | Buy | $430.00 from $400.00 | Apr 20, 2026 |
| JP Morgan | Maintained | Overweight | $410.00 from $360.00 | Apr 16, 2026 |
Frequently asked questions
What is the price target for CLS stock?
The average 12-month analyst price target for Celestica (CLS) is $455.86, with a high estimate of $520.00 and a low of $375.00, across 7 analysts.
Is CLS a buy, sell, or hold?
Analysts covering Celestica currently average a Buy rating: 24 buy, 0 hold and 0 sell, from 24 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CLS?
The average price target of $455.86 implies 40.99% upside from the last price of $323.32.
What is the latest analyst rating on CLS?
On Sep 30, 2026, Bernstein initiated coverage of Celestica at Outperform with a price target of $520.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.